Nutritional markers, not markers of bone turnover, are related predictors of bone mineral density in chronic peritoneal dialysis patients

Clinical Nephrology

Volumn 74, Issue 5, 2010, Pages 336-342

  Jeong, J U ^a   Lee, H K ^a   Kim, Y J ^a   Kim, J S ^a   Kang, S S ^a   Kim, S B ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Bone density; Nutritional status; Peritoneal dialysis

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE BONE ISOENZYME; BIOLOGICAL MARKER; BMI1 PROTEIN; CALCIFEDIOL; CARBOXY TERMINAL TELOPEPTIDE; OSTEOCALCIN; PALLADIUM; PARATHYROID HORMONE; PREALBUMIN;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE TURNOVER; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; HUMAN; INDEPENDENT VARIABLE; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOPENIA; OSTEOPOROSIS; PARATHYROID HORMONE BLOOD LEVEL; PERITONEAL DIALYSIS; PREDICTOR VARIABLE; WORLD HEALTH ORGANIZATION;

EID: 78649852147     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp74336     Document Type: Article

References (29)

1. Alem AM, Sherrard DJ, Gillen DL, Weiss NS, Beresford SA, Heckbert SR, Wong C, Stehman-Breen C. Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int. 2000; 58: 396-399.
2. Ersoy FF. Osteoporosis in the elderly with chronic kidney disease. Int Urol Nephrol. 2007; 39: 321-331.
3. Taal MW, Masud T, Green D, Cassidy MJ. Risk factors for reduced bone density in haemodialysis patients. Nephrol Dial Transplant. 1999; 14: 1922-1928.
4. Ersoy F, Passadakis S, Tam P, Memmos E, Katopodis P, Ozener C, Akcicek F, Camsari T, Ates K, Ataman R, Vlachojannis J, Dombros A, Utas C, Akpolat T, Bozfakioglu S, Wu G, Karayaylali I, Arinsoy T, Stathakis P, Yavuz M, Tsakiris J, Dimitriades C, Yilmaz M, Gultekin M, Karayalcin B, Yardimsever M, Oreopoulos D. Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis patients. J Bone Miner Metab. 2006; 24: 79-86.
5. Zayour D, Daouk M, Medawar W, Salamoun M, El-Hajj FG. Predictors of bone mineral density in patients on hemodialysis. Transplant Proc. 2004; 36: 1297-1301.
6. Asaka M, Iida H, Entani C, Fujita M, Izumino K, Takata M, Seto H, Sasayama S. Total and regional bone mineral density by dual photon absorptiometry in patients on maintenance hemodialysis. Clin Nephrol. 1992; 38: 149-153.
7. Urena P, Bernard-Poenaru O, Ostertag A, Baudoin C, Cohen-Solal M, Cantor T, de Vernejoul MC. Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients. Nephrol Dial Transplant. 2003; 18: 2325-2331.
8. Tsuchida T, Ishimura E, Miki T, Matsumoto N, Naka H, Jono S, Inaba M, Nishizawa Y. The clinical significance of serum osteocalcin and N-terminal propeptide of type I collagen in predialysis patients with chronic renal failure. Osteoporos Int. 2005; 16: 172-179.
9. Elder G, Mackun K. 25-hydroxyvitamin D deficiency and diabetes predict reduced BMD in patients with chronic kidney disease. J Bone Miner Res. 2006; 21: 1778-1784.
10. Rico H, Relea P, Revilla M, Hernandez E, Arribas I, Villa L. Biochemical markers of nutrition in osteoporosis. Calcif Tissue Int. 1993; 52: 331-333.
11. Rico H, Relea P, Crespo R, Revilla M, Villa L, Arribas I, Usabiaga J. Biochemical markers of nutrition in type-I and type-II osteoporosis. J Bone Joint Surg Br. 1995; 77: 148-151.
12. Thiebaud D, Burckhardt P, Costanza M, Sloutskis D, Gilliard D, Quinodoz F, Jacquet AF, Burnand B. Importance of albumin, 25(OH)-vitamin D and IGFBP-3 as risk factors in elderly women and men with hip fracture. Osteoporos Int. 1997; 7: 457-462.
13. Huang Z, Himes J, McGovern P. Nutrition and subsequent hip fracture risk among a national cohort of white women. Am J Epidemiol. 1996; 144: 124-134.
14. Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18: 499-502.
15. Blake PG. Adequacy of peritoneal dialysis and chronic peritoneal dialysis prescription. In: Daugirdas JT, Blake PG, Ing TS (eds). Handbook of dialysis. 4th Edition. Philadelphia: Lippincott Williams and Wilkins; 2007. p. 387-409.
16. Coin A, Sergi G, Beninca P, Lupoli L, Cinti G, Ferrara L, Benedetti G, Tomasi G, Pisent C, Enzi G. Bone mineral density and body composition in underweight and normal elderly subjects. Osteoporos Int. 2000; 11: 1043-1050.
17. Huang GS, Chu TS, Lou MF, Hwang SL, Yang RS.Factors associated with low bone mass in the hemodialysis patients - a cross-sectional correlation study. BMC Musculoskelet Disord. 2009; 10: 60.
18. Negri A, Barone R, Quiroga M, Bravo M, Marino A, Fradinger E, Bogado C, Zanchetta J. Bone mineral density. Serum markers of bone turnover and their relationships in peritoneal dialysis. Perit Dial Int. 2004; 24: 163-168.
19. Ha SK, Park CH, Seo JK, Park SH, Kang SW, Choi KH, Lee HY, Han DS. Studies on bone markers and bone mineral density in patients with chronic renal failure. Yonsei Med J. 1996; 37: 350-356.
20. 3, and radiology in end-stage renal disease. Kidney Int. 1993; 44: 1071-1077.
21. Taskapan H, Ersoy FF, Passadakis PS, Tam P, Memmos DE, Katopodis KP, Ozener C, Akcicek F, Camsari T, Ates K, Ataman R, Vlachojannis JG, Dombros NA, Utas C, Akpolat T, Bozfakioglu S, Wu G, Karayaylali I, Arinsoy T, Stathakis CP, Yavuz M, Tsakiris DJ, Dimitriades AD, Yilmaz ME, Gultekin M, Oreopoulos DG. Severe vitamin D deficiency in chronic renal failure patients on peritoneal dialysis. Clin Nephrol. 2006; 66: 247-255.
22. Coen G, Mantella D, Manni M, Balducci A, Nofroni I, Sardella D, Ballanti P, Bonucci E. 25-hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy. Kidney Int. 2005; 68: 1840-1848.
23. Stavroulopoulos A, Porter C, Roe S, Hosking D, Cassidy M. Relationship between vitamin D status, parathyroid hormone levels and bone mineral density in patients with chronic kidney disease stages 3 and 4. Nephrology (Carlton). 2008; 13: 63-67.
24. Tomida K, Hamano T, Mikami S, Fujii N, Okada N, Matsui I, Nagasawa Y, Moriyama T, Ito T, Imai E, Isaka Y, Rakugi H. Serum 25-hydroxyvitamin D as an independent determinant of 1-84 PTH and bone mineral density in non-diabetic predialysis CKD patients. Bone. 2009; 44: 678-683.
25. Nakamura K. Vitamin D insufficiency in Japanese populations: From the viewpoint of the prevention of osteoporosis. J Bone Miner Metab. 2006; 24: 1-6.
26. Aloni Y, Shany S, Chaimovitz C. Losses of 25-hydroxyvitamin D in peritoneal fluid. Possible mechanism for bone disease in uremic patients treated with chronic ambulatory peritoneal dialysis. Miner Electrolyte Metab. 1983; 9: 82-86.
27. Baszko-Blaszyk D, Grzegorzewska A, Horst-Sikorska W, Sowinski J. Bone mass in chronic renal insufficiency patients treated with continuous ambulatory peritoneal dialysis. Adv Perit Dial. 2001; 17: 109-113.
28. Koh JM, Khang YH, Jung CH, Bae S, Kim DJ, Chung YE, Kim GS. Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre- and postmenopausal women. Evidence for a link between systemic inflammation and osteoporosis. Osteoporos Int. 2005; 16: 1263-1271.
29. Kim BJ, Yu YM, Kim EN, Chung YE, Koh JM, Kim GS. Relationship between serum hsCRP concentration and biochemical bone turnover markers in healthy pre- and postmenopausal women. Clin Endocrinol (Oxf). 2007; 67: 152-158.